Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Grant Sean, Chief Financial Officer. Officer active across 1 company, notably Vera Therapeutics, Inc.. In total, 11 reports have been logged. Split: 4 buys · 1 sell. Total volume traded: €468k. Activity tracked since 15 June 2022. The latest transaction was disclosed on 23 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Grant Sean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,816 shares@ US$13.60080.0010% mcap100.0% of flowClass A Common StockSEC:0001209191-22-037401:0
Canonical exit: 13 Sept 2022 (T+90)
11 of 11 declarations
About Grant Sean
Sean Grant serves as Chief Financial Officer at Vera Therapeutics, Inc. In this role, he oversees the company's financial management, including financial planning, risk management, and regulatory compliance. Sean plays a key role in optimizing financial resources and in strategic decision-making to support the company's growth.